Healthcare - Biotechnology - NASDAQ - CN
$ 2.16
-6.9 %
$ 95.6 M
Market Cap
-2.96
P/E
BALANCE SHEET
116 M
ASSETS
45.2 M
LIABILITIES
70.6 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Adagene Inc.
| Current Assets | 113 M |
| Cash & Short-Term Investments | 110 M |
| Receivables | 222 K |
| Other Current Assets | 3.29 M |
| Non-Current Assets | 2.29 M |
| Long-Term Investments | 0 |
| PP&E | 2.2 M |
| Other Non-Current Assets | 84.9 K |
| Current Liabilities | 31.5 M |
| Accounts Payable | 3.09 M |
| Short-Term Debt | 8.59 M |
| Other Current Liabilities | 19.8 M |
| Non-Current Liabilities | 13.7 M |
| Long-Term Debt | 13.7 M |
| Other Non-Current Liabilities | 0 |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 109.9 | 143.8 | 174.4 | 75.2 | 92.5 | 16.1 |
| Short Term Investments | 0 | 0 | 0 | 0 | 8.0 | 33.0 |
| Receivables | 0.2 | 0.6 | 7.5 | 0.1 | 2.1 | 1.4 |
| Inventory | 0 | 0 | 1 | 0 | 1 | 0 |
| Other Current Assets | 3.3 | 4.9 | 4.1 | 3.8 | 1.2 | 1.3 |
| Total Current Assets | 113.4 | 149.3 | 186.0 | 79.1 | 103.9 | 51.8 |
| PP&E | 2.2 | 3.0 | 3.5 | 2.1 | 1.9 | 2.6 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0 | 0 | 7.2 | 0.2 | 0.2 |
| Other Long Term Assets | 84.9 K | 0.1 | 69.3 K | (4.1) | (0.1) | (0.1) |
| Other Assets | 1 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 115.7 | 152.4 | 189.5 | 84.3 | 105.9 | 54.4 |
| LIABILITIES | ||||||
| Accounts Payable | 3.1 | 3.7 | 3.3 | 1.8 | 0.7 | 0.6 |
| Short Term Debt | 8.6 | 13.8 | 4.5 | 5.0 | 1.0 | 2.3 |
| Other Current Liabilities | 19.7 | 22.2 | 14.8 | 8.5 | 4.4 | 7.4 |
| Total Current Liabilities | 31.5 | 55.1 | 29.8 | 16.1 | 7.2 | 10.3 |
| Long Term Debt | 13.7 | 14.2 | 3.0 | 3.0 | 1.5 | 0 |
| Deferred Tax Income | 0 | 0 | 44.2 K | 0 | 0 | 0 |
| Other Liabilities | 0 | 28.7 K | 94.1 K | 154.5 | 154.2 | 85.1 |
| Total Liabilities | 45.2 | 69.3 | 33.0 | 173.7 | 162.9 | 95.4 |
| EQUITY | ||||||
| Common Stock | 5.55 K | 5.5 K | 5.63 K | 1.89 K | 1.52 K | 1.52 K |
| Retained Earnings | (277.8) | (258.8) | (178.8) | (105.7) | (63.3) | (46.8) |
| Other Accumulative Comprehensive Income/Loss | (1.8) | (0.8) | 94 K | (0.4) | (0.3) | (0.4) |
| Total Equity | 70.6 | 83.1 | 156.6 | (89.4) | (57.0) | (41.0) |
| Total Liabilities and Equity | 115.7 | 152.4 | 189.5 | 84.3 | 105.9 | 54.4 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 43.3 | 43.3 | 40.0 | 35.1 | 44.2 | 34.4 |